Certified by Founder Lodge
iDEL Therapeutics GmbH
Germany - Dortmund, Nordrhein-Westfalen
START UP
1 Disclosed Funding Rounds $10,381,635
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
iDEL Therapeutics is a biotechnology company developing a pioneering drug delivery platform designed to transport therapeutic payloads directly into the cytosol of tumor cells.
Our proprie
BiomedVC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Quorus | $5,000,000 | (Mar 18, 2026)
Turquoise(US) | $40,000,000 | (Mar 18, 2026)
R1 Therapeutics | $77,500,000 | (Mar 18, 2026)
Conduit Health | $17,000,000 | (Mar 18, 2026)
